Skip to main content
. 2011 Nov 23;6(11):e27769. doi: 10.1371/journal.pone.0027769

Table 1. Bronchoscopy and sedative outcomes.

BIS-guided Propofol Sedation (n = 243) Clinically-judged Midazolam Sedation(n = 249) p value
Induction
P/M dose, mg 54.5 (16.4) 3.8 (2.5)
A dose, µg 295.0 (54.8) 285.2 (56.4) 0.052
Induction time,* min 3.4 (1.6) 5.3 (3.1) <0.001
Total procedures
P/M dose, mg 198.6 (102.7) 6.8 (3.9)
A dose, µg 325.4 (101.7) 350.3 (117.1) 0.012
Mean BIS level 70.8 (6.1)
Procedure time, min 25.8 (15.2) 25.5 (16.2) 0.810
Recovery time, min
Time to orientation 11.5 (10.2) 30.0 (26.8) <0.001
Time to ambulation 30.0 (18.1) 55.7 (40.6) <0.001
Safety #
SpO2 <90% 97 (39.9) 89 (35.7) 0.340
MAP <60 mm Hg 11 (4.5) 4 (1.6) 0.060
SBP <90 mm Hg 18 (7.4) 11 (4.4) 0.159

Data is presented as mean (SD) unless otherwise indicated.

Abbreviations: P, propofol; M, midazolam; A, alfentanil; SpO2: oxyhemoglobin saturation; MAP: mean arterial blood pressure; SBP: systolic blood pressure.

*From alfentanil administration to BIS level 70 in the study group, or conscious sedation in the control group.

†From insertion of bronchoscope to its removal.

‡Patients could open eyes spontaneously, correctly recall date of birth, and perform finger-nose test.

¶Patients could walk without assistance.

# The number of patients with at least one event of hypoxemia or hypotension during the entire procedure (percent).